Public, NASDAQ:GPCB
NASDAQ Global Market
GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008
Date: Thu, 14 Aug 2008 23:18:31 GMT
Tags:
GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008
Ad-Hoc-News (Pressemitteilung) - Aug 14, 2008
Ad-Hoc-News (Pressemitteilung) - Aug 14, 2008
* Cash , cash equivalents , marketable securities and short - term investments of ~ยค 44.6 million ( approx . $67 million ) as of June 30 , 2008 * Company confirms that existing cash position ...
GPC Biotech Q2 Net Loss Narrows on Lower Expenses; backs 2008 revenue view - Update
Date: Wed, 13 Aug 2008 07:36:51 GMT
Tags:
GPC Biotech Q2 Net Loss Narrows on Lower Expenses; backs 2008 revenue view - Update
RTT News - Aug 13, 2008
RTT News - Aug 13, 2008
( RTTNews ) - GPC Biotech AG ( GPCB : News , Chart , Quote ) , a biopharmaceutical company focused on anticancer drugs , reported Wednesday a narrower net loss for the second quarter , on the ...
GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008
Date: Wed, 13 Aug 2008 05:47:30 GMT
Tags:
GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008
MarketWatch - Aug 13, 2008
MarketWatch - Aug 13, 2008
- - - - - - - - - - Operating loss ( 14,782 ) ( 41,365 ) Other income ( expense ) , net 359 89 Interest income 1,079 2,077 Interest expense ( 44 ) ( 67 ) - - - - - - - - - - - - - - - - - - - ...
GPC Biotech Schedules Conference Call on August 13th to Discuss First Half 2008 Financial Results
Date: Tue, 12 Aug 2008 09:01:56 GMT
Tags:
GPC Biotech Schedules Conference Call on August 13th to Discuss First Half 2008 Financial Results
MarketWatch - Aug 12, 2008
MarketWatch - Aug 12, 2008
, , ) today announced that it will hold a conference call on Wednesday , August 13 , 2008 to discuss its financial results for the second quarter and first half of 2008.The results will be published ...
GPC Biotech Schedules Conference Call on August 13 th to Discuss First Half 2008 Financial Results - Business Wire (press release)GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
Date: Wed, 06 Aug 2008 22:16:52 GMT
Tags:
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin
MarketWatch - Aug 6, 2008
Celgene pulls out of GPC prostate cancer drug deal - Reuters
Forbes - RTT News - The Star-Ledger - NJ.com
MarketWatch - Aug 6, 2008
, , ) today reported that the Company has received notice from Celgene Corporation of its decision to terminate its co - development and license agreement with GPC Biotech for satraplatin in ...
GPC Biotech Says Celgene Decides to Terminate Satraplatin Deal - BloombergCelgene pulls out of GPC prostate cancer drug deal - Reuters
Forbes - RTT News - The Star-Ledger - NJ.com
Eli Lilly's Dose of Disclosure (at Motley Fool)
Date: Thu, 25 Sep 2008 20:19:04 Etc/GMT
Tags:
GPC Biotech AG Earnings Call scheduled for 8:00 am ET today (CCBN)
Date: Wed, 13 Aug 2008 12:00:00 Etc/GMT
Tags:
GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008 (Business Wire)
Date: Wed, 13 Aug 2008 05:35:00 Etc/GMT
Tags:
MARTINSRIED, Germany & MUNICH, Germany & PRINCETON, N.J.----GPC Biotech AG today reported financial results for the second quarter and first six months ended June 30, 2008.
GPC Biotech Schedules Conference Call on August 13th to Discuss First Half 2008 Financial Results (Business Wire)
Date: Tue, 12 Aug 2008 08:47:00 Etc/GMT
Tags:
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.----GPC Biotech AG today announced that it will hold a conference call on Wednesday, August 13, 2008 to discuss its financial results for the second quarter and first half of 2008.
GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin (Business Wire)
Date: Wed, 6 Aug 2008 22:01:00 Etc/GMT
Tags:
MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.----GPC Biotech AG today reported that the Company has received notice from Celgene Corporation of its decision to terminate its co-development and license agreement with GPC Biotech for satraplatin in Europe, Turkey, the Middle East, Australia and New Zealand.